Evotec AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Evotec AG O.N. (EVTd)
Evotec AG O.N. stock price live, this page displays ETR EVTG stock exchange data. View the EVTG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Evotec AG O.N. real time stock price chart below.
What Is the Evotec AG O.N. Stock Price Today?
The Evotec AG O.N. stock price today is 6.23.
What Is the Stock Symbol for Evotec AG O.N.?
The stock symbol for Evotec AG O.N. is ""EVTG.""
What Stock Exchange Does Evotec AG O.N. Trade On?
Evotec AG O.N. is listed and trades on the Xetra stock exchange.
Is Evotec AG O.N. a Good Stock to Buy?
Determining whether Evotec AG O.N.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVTG quote. (ISIN: DE0005664809)
What Is the Evotec AG O.N. Stock Price Today?
The Evotec AG O.N. stock price today is 6.23.
What Is the Stock Symbol for Evotec AG O.N.?
The stock symbol for Evotec AG O.N. is ""EVTG.""
What Stock Exchange Does Evotec AG O.N. Trade On?
Evotec AG O.N. is listed and trades on the Xetra stock exchange.
Is Evotec AG O.N. a Good Stock to Buy?
Determining whether Evotec AG O.N.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EVTG quote. (ISIN: DE0005664809)
6.23
+0.04(+0.65%)
Closed·
Fair Value
An estimate of a Evotec AG O.N.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.23
6.23
52 wk Range
5.20
10.04
EVTd Scorecard
Full Analysis
High shareholder yield
EVTd is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Evotec AG O.N.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.236.23
52 wk Range
5.2010.04
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
EVTd Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Evotec AG O.N.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Evotec SE ADR receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Evotec AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Evotec AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Evotec AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Evotec AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Evotec AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Evotec stock rises following Q4 earnings beat
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Evotec AG O.N. Company Profile
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. The company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Compare EVTd to Peers and Sector
Metrics to compare | EVTd | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVTdPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.4x | 13.1x | −0.5x | |
PEG Ratio | 0.04 | 0.01 | 0.00 | |
Price/Book | 1.2x | 2.5x | 2.6x | |
Price / LTM Sales | 1.4x | 3.2x | 3.2x | |
Upside (Analyst Target) | - | 353.9% | 41.9% | |
Fair Value Upside | Unlock | 16.1% | 4.3% | Unlock |
Earnings
Latest Release
May 06, 2025
EPS / Forecast
-0.18 / -0.02
Revenue / Forecast
199.98M / 232.40M
People Also Watch
FAQ
What Stock Exchange Does Evotec AG O.N. Trade On?
Evotec AG O.N. is listed and trades on the BATS Europe stock exchange.
What Is the Stock Symbol for Evotec AG O.N.?
The stock symbol for Evotec AG O.N. is "EVTd."
What Is the Evotec AG O.N. Market Cap?
As of today, Evotec AG O.N. market cap is 1.13B.
What Is Evotec AG O.N.'s Earnings Per Share (TTM)?
The Evotec AG O.N. EPS (TTM) is -1.17.
When Is the Next Evotec AG O.N. Earnings Date?
Evotec AG O.N. will release its next earnings report on 12 Aug 2025.
From a Technical Analysis Perspective, Is EVTd a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Evotec AG O.N. Stock Split?
Evotec AG O.N. has split 0 times.
How Many Employees Does Evotec AG O.N. Have?
Evotec AG O.N. has 4766 employees.
What is the current trading status of Evotec AG O.N. (EVTd)?
As of 24 Jul 2025, Evotec AG O.N. (EVTd) is trading at a price of 6.23, with a previous close of 6.23. The stock has fluctuated within a day range of 6.23 to 6.23, while its 52-week range spans from 5.20 to 10.04.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.